Nocturne Acquisition Corp

Track all markets on TradingView Nocturne Acquisition Corp (ticker: MBTC), a special purpose acquisition company (SPAC), faces increased costs and time constraints as the Securities and Exchange Commission (SEC) recently issued proposed rules related to disclosure, financial statement requirements, and potential liability amongst others for SPACs. The company is currently paying its sponsor a monthly […]

Track all markets on TradingView Nocturne Acquisition Corp (MBTC) has entered into a merger agreement and plans to domesticate as a Delaware corporation, renaming itself Cognos Therapeutics Holdings, Inc. The company recently reported its financial activities and subsequent events from their initial public offering (IPO) in April 2021. Their primary objective is to execute a

Track all markets on TradingView Nocturne Acquisition Corp (MBTC), a special-purpose acquisition company (SPAC), has experienced a significant reduction in its ordinary shares subject to possible redemption in 2022, according to its recent SEC report. This analysis presents an in-depth look into Nocturne’s financial status using available facts and statistics. Substantial Decline in Ordinary Shares

Track all markets on TradingView The Special Purpose Acquisition Company (SPAC) Nocturne Acquisition Corp (ticker: MBTC), currently focused on completing its initial business combination with Cognos, has set October 5, 2023, as the deadline for the completion of this combination. According to the company’s recent SEC report, failure to complete the business combination within the

Track all markets on TradingView Nocturne Acquisition Corporation (NASDAQ: MBTC), a Cayman Islands-based blank-check company, has reported a surge in its total assets with $21.65 million as of March 31, 2023, according to the firm’s recent SEC Form 10-Q filing. Established in 2020, the company aims to merge, acquire, or reorganize assets and businesses for